Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
International Journal of Molecular Sciences
|
December 17, 2024
High-Throughput Drug Screening in Chondrosarcoma Cells Identifies Effective Antineoplastic Agents Independent of IDH Mutation
Luyuan Li, Lily Hashemi, Josiane Eid, et al.
Journal of Cardiac Surgery
|
January 18, 2017
Management of sickle cell disease in patients undergoing cardiac surgery
Todd C Crawford, Michael V Carter, Rina K Patel, et al.
Clinical Transplantation
|
May 14, 2020
Multiorgan procurement is associated with a survival benefit after heart transplantation
Jonathan Trent Magruder, Yoshikazu Suzuki, Alexandra Sperry, et al.
Cancer Investigation
|
May 5, 2023
Gastrointestinal Stromal Tumor Patients with Molecular Testing Exhibit Superior Survival Compared to Patients without Testing: Results from the Life Raft Group (LRG) Registry
Jerry Call, Jonathan Wojtkowiak, Denisse Evans, et al.
JAMA Network Open
|
August 20, 2021
Variation in Management of Extremity Soft-Tissue Sarcoma in Younger vs Older Adults
Crystal Seldon, Gautam Shrivastava, Abdurrahman Al-Awady, et al.
Cancer Biology & Medicine
|
November 24, 2021
The efficacies and biomarker investigations of antiprogrammed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu, Ting Li, Zhichao Liao, et al.
Brachytherapy
|
June 4, 2023
CivaSheet® use for soft tissue sarcoma: A single institution experience
Crystal Seldon, Julie G Grossman, Gautam Shrivastava, et al.
Annals of Internal Medicine
|
September 22, 2010
Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial
Saroj Vadhan-Raj, Jonathan Trent, Shreyaskumar Patel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 9, 2016
Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour
Andrew J Wagner, Mark Agulnik, Michael C Heinrich, et al.
Current Treatment Options in Oncology
|
April 5, 2023
Osteogenic Sarcoma of the Head and Neck: Is Chemotherapy Needed?
Steven Bialick, Leticia Campoverde, Jesus Antonio Ocejo Gallegos, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
International Journal of Molecular Sciences
|
December 17, 2024
High-Throughput Drug Screening in Chondrosarcoma Cells Identifies Effective Antineoplastic Agents Independent of IDH Mutation
Luyuan Li, Lily Hashemi, Josiane Eid, et al.
Journal of Cardiac Surgery
|
January 18, 2017
Management of sickle cell disease in patients undergoing cardiac surgery
Todd C Crawford, Michael V Carter, Rina K Patel, et al.
Clinical Transplantation
|
May 14, 2020
Multiorgan procurement is associated with a survival benefit after heart transplantation
Jonathan Trent Magruder, Yoshikazu Suzuki, Alexandra Sperry, et al.
Cancer Investigation
|
May 5, 2023
Gastrointestinal Stromal Tumor Patients with Molecular Testing Exhibit Superior Survival Compared to Patients without Testing: Results from the Life Raft Group (LRG) Registry
Jerry Call, Jonathan Wojtkowiak, Denisse Evans, et al.
JAMA Network Open
|
August 20, 2021
Variation in Management of Extremity Soft-Tissue Sarcoma in Younger vs Older Adults
Crystal Seldon, Gautam Shrivastava, Abdurrahman Al-Awady, et al.
Cancer Biology & Medicine
|
November 24, 2021
The efficacies and biomarker investigations of antiprogrammed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu, Ting Li, Zhichao Liao, et al.
Brachytherapy
|
June 4, 2023
CivaSheet® use for soft tissue sarcoma: A single institution experience
Crystal Seldon, Julie G Grossman, Gautam Shrivastava, et al.
Annals of Internal Medicine
|
September 22, 2010
Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial
Saroj Vadhan-Raj, Jonathan Trent, Shreyaskumar Patel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 9, 2016
Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour
Andrew J Wagner, Mark Agulnik, Michael C Heinrich, et al.
Current Treatment Options in Oncology
|
April 5, 2023
Osteogenic Sarcoma of the Head and Neck: Is Chemotherapy Needed?
Steven Bialick, Leticia Campoverde, Jesus Antonio Ocejo Gallegos, et al.
Page
of 8